Viewing profile — refoundable
refoundable
HN member- Joined
- Mon, Dec 28, 2020, 1:42 PM UTC
- HN karma
- 41
- Public activity
- 17 items
- HN profile
- View on Hacker News ↗
About refoundable
No profile information was provided.
Recent public activity
-
comment
Comment #25574902
> Why do you think that cheaper development costs will ultimately lead to lower drug prices? If the cost of drug development were to drop by a factor of 100-1000, say from the $3B …
-
comment
Comment #25564005
Thanks for the great catch. Fixed.
-
comment
Comment #25563055
That's certainly what's implied by Scannell's answer to Question 8, but such a solution comes with its own set of limitations related to design by committee. Small startup teams ar…
-
comment
Comment #25562844
No disagreement on the skewed stats. And I won't dispute the need for a minimum standard of efficacy. However, if anything, the problem that we've had over the last 60 years is set…
-
comment
Comment #25562645
On angiogenesis, see Judah Folkman: https://www.tobinproject.org/about/judah-folkman On cancer immunotherapy, see Fran Visco's story as partially told by Daniel Sarewitz (section t…
-
comment
Comment #25562514
I echo both observations and urge you to name that law. Will look under the hood at the CSS.
-
comment
Comment #25562072
It's worth noting that the most effectives breakthroughs against cancer in recent decades (Immunotherapy, angiogenesis-suppressing drugs) have largely been based on ideas that were…
-
comment
Comment #25561898
You're right on the money. Any breakthrough that could either dramatically shorten the feedback cycle (from years to weeks), or reduce the cost of drug development by 100-1000x wou…
-
comment
Comment #25561261
I see no reason why we can't do both. We obviously need better drugs for the diseases we haven't yet cured, and we need cheaper drugs for the diseases we've already cured. The two …
-
comment
Comment #25561142
> Having better tox models seems like the highest value, albeit very difficult, route here. Which to me is a separate, more general, problem than a specific disease model. Agreed. …
-
comment
Comment #25561095
I agree that discovery is far from a straight-forward process, and that many of the cavalier ways in which it happened in decades past would be criminally prosecuted and beyond the…
-
comment
Comment #25560830
The FDA does not allow Pharma companies to create safe and slightly less effective drugs than the best-in-class, even if such drugs were 10-100x cheaper and would thus alleviate mo…
-
comment
Comment #25559721
Most people tend to focus on the cost side of Eroom's law, but I find its most disturbing implication to be the other side: That between 1950 and 2010, we got ~100x worse at findin…
-
comment
Comment #25559493
Thank you. It takes a fair bit of time to put something like this together, so I appreciate your kind words.
-
comment
Comment #25559417
Author here. I interviewed Jack Scannell on the hypothesis that the man who wrote the now famous paper on Eroom's law would likely have many more insights to offer that didn't nece…
-
comment
Comment #25559364
A more accurate definition pulled from the introduction: > Eroom’s law is the observation that the cost of developing a new drug roughly doubled every nine years from 1950 through …
-
comment
Comment #25559137
No idea what's causing this for you. Can you say a bit more about your setup?